Nazeh Mohammed Al-Abd
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nazeh Mohammed Al-Abd has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
Mustafa Kassim
Department of Anesthesiology Faculty of Medicine University of Malaya 50603 Kuala Lumpur Malaysia
5 shared publicationsMarzida Mansor
B Faculty of Medicine, Department of Anesthesiology , University of Malaya , Kuala Lumpur , Malaysia
4 shared publications- Abdulelah Hussien Al-Adhroey
Department of Community Medicine, Faculty of Medicine and Health Sciences, Thamar University, Dhamar, Yemen
3 shared publications - Mohd Shahnaz Hasan
Department of Anesthesiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia
3 shared publications Zurainee Mohamed Nor
A Faculty of Medicine, Department of Parasitology , University of Malaya , Kuala Lumpur , Malaysia
3 shared publications- Gamila Saleh Ali
Department of Medicine, Faculty of Medicine and Health Sciences, University of Aden, Aden, Yemen
2 shared publications
Latest Publications
- Open Access
- 20 July 2026
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 26 (1)
AI-assisted decision support for sickle cell disease severity stratification using routine blood tests: a systematic review and meta-analysis
- 20 July 2026
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 26 (1)
Open AccessAI-assisted decision support for sickle cell disease severity stratification using routine blood tests: a systematic review and meta-analysis
- Open Access
- 14 February 2026
- Published by Elsevier in IJID Regions
- Vol. 18, 100861
Critical immunity gaps: Waning diphtheria protection among Yemen’s displaced populations calls for urgent booster strategies
- 14 February 2026
- Published by Elsevier in IJID Regions
- Vol. 18, 100861
Open AccessCritical immunity gaps: Waning diphtheria protection among Yemen’s displaced populations calls for urgent booster strategies
- Open Access
- 1 January 2026
- Published by Wiley in Human Mutation
- Vol. 2026 (1) , 9405486
AI‐Augmented Hematological Signatures for Equitable Detection of Hereditary Hemolytic Anemia Carriers: A Global Systematic Review and Meta‐Analysis
Artificial intelligence (AI) augmentation of routine hematological tests offers a promising strategy to improve hereditary hemolytic anemia (HHA) carrier detection in premarital screening, especially in resource‐limited settings. HHA in this review specifically encompasses β ‐thalassemia, α ‐thalassemia, sickle cell disease (including HbS and HbC variants), and other hemoglobinopathies with autosomal recessive inheritance patterns requiring carrier detection for prevention. These conditions share hemolytic phenotypes but differ in hematological signatures, necessitating separate subgroup analyses. This global systematic review and meta‐analysis evaluated the diagnostic accuracy, equity implications, and implementation challenges of AI‐augmented complete blood count (CBC), blood smear, and erythrocyte sedimentation rate (ESR) for HHA carrier identification. We systematically searched seven databases and included 85 studies ( n = 133,498 participants, 23 countries). AI‐augmented screening achieved a pooled sensitivity of 92.8% (95% CI: 91.3%–94.1%) and specificity of 91.5% (89.7%–93.0%), representing a 12.3% sensitivity improvement over conventional interpretation ( p < 0.001). However, significant geographic disparities were observed: sensitivity in Sub‐Saharan Africa was 86.5% compared with 94.8% in the Middle East ( p < 0.001), partly due to algorithmic bias against African HbS/HbC variants and infrastructural barriers. Deep learning models achieved the highest sensitivity (95.1%), whereas explainable artificial intelligence (XAI) provided optimal specificity (94.3%). Integrating CBC with blood smear increased specificity by 5.5% at minimal additional cost. AI triage reduced confirmatory testing by 23.7%, saving $8.50 per individual. For equitable implementation, we recommend the following: (1) federated learning to include underrepresented genotypes, (2) WHO/CDC certification of affordable, offline‐capable edge AI devices, and (3) mandatory XAI compliance with bias audits. AI can transform HHA screening, but deliberate efforts are needed to avoid exacerbating global health inequities. Importantly, 68% of validation studies used research‐grade rather than routine clinical samples, and prospective clinic‐to‐algorithm validation remains a critical gap requiring urgent attention before real‐world deployment.
- 1 January 2026
- Published by Wiley in Human Mutation
- Vol. 2026 (1) , 9405486
Open AccessAI‐Augmented Hematological Signatures for Equitable Detection of Hereditary Hemolytic Anemia Carriers: A Global Systematic Review and Meta‐Analysis
Artificial intelligence (AI) augmentation of routine hematological tests offers a promising strategy to improve hereditary hemolytic anemia (HHA) carrier detection in premarital screening, especially in resource‐limited settings. HHA in this review specifically encompasses β ‐thalassemia, α ‐thalassemia, sickle cell disease (including HbS and HbC variants), and other hemoglobinopathies with autosomal recessive inheritance patterns requiring carrier detection for prevention. These conditions share hemolytic phenotypes but differ in hematological signatures, necessitating separate subgroup analyses. This global systematic review and meta‐analysis evaluated the diagnostic accuracy, equity implications, and implementation challenges of AI‐augmented complete blood count (CBC), blood smear, and erythrocyte sedimentation rate (ESR) for HHA carrier identification. We systematically searched seven databases and included 85 studies ( n = 133,498 participants, 23 countries). AI‐augmented screening achieved a pooled sensitivity of 92.8% (95% CI: 91.3%–94.1%) and specificity of 91.5% (89.7%–93.0%), representing a 12.3% sensitivity improvement over conventional interpretation ( p < 0.001). However, significant geographic disparities were observed: sensitivity in Sub‐Saharan Africa was 86.5% compared with 94.8% in the Middle East ( p < 0.001), partly due to algorithmic bias against African HbS/HbC variants and infrastructural barriers. Deep learning models achieved the highest sensitivity (95.1%), whereas explainable artificial intelligence (XAI) provided optimal specificity (94.3%). Integrating CBC with blood smear increased specificity by 5.5% at minimal additional cost. AI triage reduced confirmatory testing by 23.7%, saving $8.50 per individual. For equitable implementation, we recommend the following: (1) federated learning to include underrepresented genotypes, (2) WHO/CDC certification of affordable, offline‐capable edge AI devices, and (3) mandatory XAI compliance with bias audits. AI can transform HHA screening, but deliberate efforts are needed to avoid exacerbating global health inequities. Importantly, 68% of validation studies used research‐grade rather than routine clinical samples, and prospective clinic‐to‐algorithm validation remains a critical gap requiring urgent attention before real‐world deployment.
- Open Access
- 30 June 2025
- Published by University of Aden in Electronic Journal of University of Aden for Basic and Applied Sciences
- Vol. 6 (2) , 131-140
BRUCELLOSIS: A COMPREHENSIVE REVIEW OF EPIDEMIOLOGY, PATHOGENESIS, DIAGNOSIS, TREATMENT, AND GLOBAL PREVALENCE
Brucellosis, a zoonotic disease caused by the genus Brucella, presents a significant public health concern globally, particularly in regions where animal husbandry is common. This narrative review aims to provide a comprehensive overview of the epidemiology of brucellosis, the different species of Brucella, diagnostic approaches, treatment options, and a synthesis of previous studies on its prevalence. Brucellosis affects both animals and humans, leading to economic losses in livestock and chronic health issues in humans. The review highlights the global distribution of the disease, the various Brucella species that infect different hosts, and the clinical and laboratory diagnostic methods used for detection. The treatment strategies, including the use of antibiotics, and the challenges of managing brucellosis in endemic areas are also discussed. In addition, the review consolidates findings from previous studies, particularly focusing on the prevalence of brucellosis in different geographic regions, identifying key risk factors, and suggesting areas for further research and control measures.
- 30 June 2025
- Published by University of Aden in Electronic Journal of University of Aden for Basic and Applied Sciences
- Vol. 6 (2) , 131-140
Open AccessBRUCELLOSIS: A COMPREHENSIVE REVIEW OF EPIDEMIOLOGY, PATHOGENESIS, DIAGNOSIS, TREATMENT, AND GLOBAL PREVALENCE
Brucellosis, a zoonotic disease caused by the genus Brucella, presents a significant public health concern globally, particularly in regions where animal husbandry is common. This narrative review aims to provide a comprehensive overview of the epidemiology of brucellosis, the different species of Brucella, diagnostic approaches, treatment options, and a synthesis of previous studies on its prevalence. Brucellosis affects both animals and humans, leading to economic losses in livestock and chronic health issues in humans. The review highlights the global distribution of the disease, the various Brucella species that infect different hosts, and the clinical and laboratory diagnostic methods used for detection. The treatment strategies, including the use of antibiotics, and the challenges of managing brucellosis in endemic areas are also discussed. In addition, the review consolidates findings from previous studies, particularly focusing on the prevalence of brucellosis in different geographic regions, identifying key risk factors, and suggesting areas for further research and control measures.
- Open Access
- 20 April 2025
- Published by University of Science and Technology, Yemen in Yemeni Journal For Medical Sciences
- Vol. 19 (5) , 48-57
Prevalence and Knowledge, Attitude, and Practices of Hepatitis B Virus Among Dental Students at the University of Science and Technology, Aden, Yemen
Introduction: Infection with the hepatitis B virus (HBV) continues to be a serious global public health concern, impacting a substantial proportion of the worldwide population. This study investigates the prevalence of HBV and assesses knowledge, attitudes, and practices (KAP) among dental students at the University of Science and Technology (UST) in Aden, Yemen. Methods: A cross-sectional study design was conducted among 186 dental students at the University of Science and Technology, Aden, Yemen. Blood samples were screened for HBV using ELISA, and a pre-tested questionnaire assessed KAP. Results: A significant majority (89.2%) of participants reported awareness of HBV, indicating a baseline understanding of the infection. Knowledge levels were good (41%), moderate (41.9%), and poor (16.1%). Attitudes were almost positive (64.5%), while practices were poor (31.2%), moderate (54.8%), and good (14%). None of the 142 students who provided blood samples tested positive for HBV. Conclusion: This study reveals significant knowledge gaps among UST dental students regarding HBV. Despite recognizing the disease's severity, misconceptions persisted. Targeted educational interventions are needed to enhance HBV awareness among future healthcare professionals.
- 20 April 2025
- Published by University of Science and Technology, Yemen in Yemeni Journal For Medical Sciences
- Vol. 19 (5) , 48-57
Open AccessPrevalence and Knowledge, Attitude, and Practices of Hepatitis B Virus Among Dental Students at the University of Science and Technology, Aden, Yemen
Introduction: Infection with the hepatitis B virus (HBV) continues to be a serious global public health concern, impacting a substantial proportion of the worldwide population. This study investigates the prevalence of HBV and assesses knowledge, attitudes, and practices (KAP) among dental students at the University of Science and Technology (UST) in Aden, Yemen. Methods: A cross-sectional study design was conducted among 186 dental students at the University of Science and Technology, Aden, Yemen. Blood samples were screened for HBV using ELISA, and a pre-tested questionnaire assessed KAP. Results: A significant majority (89.2%) of participants reported awareness of HBV, indicating a baseline understanding of the infection. Knowledge levels were good (41%), moderate (41.9%), and poor (16.1%). Attitudes were almost positive (64.5%), while practices were poor (31.2%), moderate (54.8%), and good (14%). None of the 142 students who provided blood samples tested positive for HBV. Conclusion: This study reveals significant knowledge gaps among UST dental students regarding HBV. Despite recognizing the disease's severity, misconceptions persisted. Targeted educational interventions are needed to enhance HBV awareness among future healthcare professionals.
- Open Access
- 30 September 2024
- Published by University of Aden in Electronic Journal of University of Aden for Basic and Applied Sciences
- Vol. 5 (3) , 331-337
RISK FACTORS FOR SUBSTANCE USE AMONG MALE SECONDARY SCHOOL STUDENTS IN ADEN GOVERNORATE, YEMEN
Substance use among secondary school students is a growing concern with significant implications for public health. This study aimed to identify the risk factors associated with substance use in a community of secondary school students in Aden Governorate, Yemen. A cross-sectional study was conducted among secondary school students in Aden governorate, using a structured questionnaire to collect data on potential risk factors for substance use. The questionnaire included measures of Peer Pressure, Academic Performance (GPA), Parental Monitoring, as well as self-esteem towards drug use. The Self-esteem among secondary students was measured using Rosenberg's Self-Esteem Scale. Descriptive and inferential statistical analyses were performed to identify significant risk factors. A total of 280 male students from 10 secondary schools (both section) of Aden governorate participated in the study, with a mean age of 17.37± 1.42 years. Risk factors associated with substance use included peer pressure (OR=2.34, 95% CI: 1.56-3.42), poor academic performance (OR=1.87, 95% CI: 1.23-2.81), lack of parental supervision (OR=1.62, 95% CI: 1.09-2.37), and low self-esteem (OR=1.45, 95% CI: 1.01-2.11). The findings highlight the complex interplay of social, familial, and individual factors in contributing to substance use among secondary school students. These results can inform targeted interventions and preventive strategies to address the identified risk factors in the community. This study identified several key risk factors for substance use among secondary school students in the community. Understanding and addressing these risk factors is vital for the development of effective preventive interventions and support systems to mitigate the impact of substance use on the health and well-being of young individuals.
- 30 September 2024
- Published by University of Aden in Electronic Journal of University of Aden for Basic and Applied Sciences
- Vol. 5 (3) , 331-337
Open AccessRISK FACTORS FOR SUBSTANCE USE AMONG MALE SECONDARY SCHOOL STUDENTS IN ADEN GOVERNORATE, YEMEN
Substance use among secondary school students is a growing concern with significant implications for public health. This study aimed to identify the risk factors associated with substance use in a community of secondary school students in Aden Governorate, Yemen. A cross-sectional study was conducted among secondary school students in Aden governorate, using a structured questionnaire to collect data on potential risk factors for substance use. The questionnaire included measures of Peer Pressure, Academic Performance (GPA), Parental Monitoring, as well as self-esteem towards drug use. The Self-esteem among secondary students was measured using Rosenberg's Self-Esteem Scale. Descriptive and inferential statistical analyses were performed to identify significant risk factors. A total of 280 male students from 10 secondary schools (both section) of Aden governorate participated in the study, with a mean age of 17.37± 1.42 years. Risk factors associated with substance use included peer pressure (OR=2.34, 95% CI: 1.56-3.42), poor academic performance (OR=1.87, 95% CI: 1.23-2.81), lack of parental supervision (OR=1.62, 95% CI: 1.09-2.37), and low self-esteem (OR=1.45, 95% CI: 1.01-2.11). The findings highlight the complex interplay of social, familial, and individual factors in contributing to substance use among secondary school students. These results can inform targeted interventions and preventive strategies to address the identified risk factors in the community. This study identified several key risk factors for substance use among secondary school students in the community. Understanding and addressing these risk factors is vital for the development of effective preventive interventions and support systems to mitigate the impact of substance use on the health and well-being of young individuals.
- Open Access
- 28 December 2017
- Published by Univ. of Malaya in Malaysian Journal of Science
- Vol. 36 (3) , 145-156
THE INHIBITORY EFFECT OF GALANGIN ON CYTOKINES AND NITRIC OXIDE IN MICROGLIA BV2 CELL LINE
Galangin is an active flavonoid compound found in various plants, and is one of the primary constituents of honey and propolis. It has antioxidant, anti-inflammatory, antimicrobial and hepatoprotective properties. This study is intended to evaluate the effects of galangin on cytokines and nitric oxide (NO) secretion from microglia BV2 after being induced with lipopolysaccharide. Microglia BV2 was incubated with Galangin (with and without LPS) and dexamethasone for 24h. NO production in the cultured supernatant was measured with the Griess reaction. IL-6, IL-10, and TNF-α levels were measured using immunoassay. Results indicated that galangin did not exert cytotoxicity effect on the cell viability of BV2 macroglia at concentrations less than 40 µg/mL. It was also observed that galangin had significantly suppressed the production of cytokines, such as IL-6, IL-10 and TNF-α, as well as NO in LPS-induced BV2 cells. The antioxidant and anti-inflammatory properties of galangin are associated with its ability to inhibit NO and cytokines. Our results further showed the potential impact of galangin, thus suggesting that further development is feasible in order to leverage on its promising antioxidant and anti-inflammatory effects in treating neuroinflammatory diseases. Key words: Galangin; Lipopolysaccharide (LPS); Nitric oxide (NO); Cytokines; Microglia BV2.
- 28 December 2017
- Published by Univ. of Malaya in Malaysian Journal of Science
- Vol. 36 (3) , 145-156
Open AccessTHE INHIBITORY EFFECT OF GALANGIN ON CYTOKINES AND NITRIC OXIDE IN MICROGLIA BV2 CELL LINE
Galangin is an active flavonoid compound found in various plants, and is one of the primary constituents of honey and propolis. It has antioxidant, anti-inflammatory, antimicrobial and hepatoprotective properties. This study is intended to evaluate the effects of galangin on cytokines and nitric oxide (NO) secretion from microglia BV2 after being induced with lipopolysaccharide. Microglia BV2 was incubated with Galangin (with and without LPS) and dexamethasone for 24h. NO production in the cultured supernatant was measured with the Griess reaction. IL-6, IL-10, and TNF-α levels were measured using immunoassay. Results indicated that galangin did not exert cytotoxicity effect on the cell viability of BV2 macroglia at concentrations less than 40 µg/mL. It was also observed that galangin had significantly suppressed the production of cytokines, such as IL-6, IL-10 and TNF-α, as well as NO in LPS-induced BV2 cells. The antioxidant and anti-inflammatory properties of galangin are associated with its ability to inhibit NO and cytokines. Our results further showed the potential impact of galangin, thus suggesting that further development is feasible in order to leverage on its promising antioxidant and anti-inflammatory effects in treating neuroinflammatory diseases. Key words: Galangin; Lipopolysaccharide (LPS); Nitric oxide (NO); Cytokines; Microglia BV2.
- 3 October 2017
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 111 (7) , 388-394
Antifilarial activity of caffeic acid phenethyl ester on Brugia pahangi in vitro and in vivo
Lymphatic filariasis (LF) is a vector borne disease caused by parasitic worms such as Wuchereria bancrofti, Brugia malayi and B. timori, which are transmitted by mosquitoes. Current therapeutics to treat LF are mainly microfilarcidal, and lack activity against adult worms. This set back, poses a challenge for the control and elimination of filariasis. Thus, in this study the activities of caffeic acid phenethyl ester (CAPE) against the filarial worm B. pahangi and its bacterial endosymbiont, Wolbachia were evaluated. Different concentrations (2, 5, 10, 15, 20 μg/ml) of CAPE were used to assess its effects on motility, viability and microfilarial (mf) production of B. pahangi in vitro. Anti-Wolbachial activity of CAPE was measured in worms by quantification of Wolbachial wsp gene copy number using real-time polymerase chain reaction. Our findings show that CAPE was found to significantly reduce adult worm motility, viability, and mf release both in vitro and in vivo. 20 μg/ml of CAPE halts the release of mf in vitro by day 6 of post treatment. Also, the number of adult worms recovered in vivo were reduced significantly during and after treatment with 50 mg/kg of CAPE relative to control drugs, diethylcarbamazine and doxycycline. Real time PCR based on the Wolbachia ftsZ gene revealed a significant reduction in Wolbachia copy number upon treatment. Anti-Wolbachia and antifilarial properties of CAPE require further investigation as an alternative strategy to treat LF.
- 3 October 2017
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 111 (7) , 388-394
Antifilarial activity of caffeic acid phenethyl ester on Brugia pahangi in vitro and in vivo
Lymphatic filariasis (LF) is a vector borne disease caused by parasitic worms such as Wuchereria bancrofti, Brugia malayi and B. timori, which are transmitted by mosquitoes. Current therapeutics to treat LF are mainly microfilarcidal, and lack activity against adult worms. This set back, poses a challenge for the control and elimination of filariasis. Thus, in this study the activities of caffeic acid phenethyl ester (CAPE) against the filarial worm B. pahangi and its bacterial endosymbiont, Wolbachia were evaluated. Different concentrations (2, 5, 10, 15, 20 μg/ml) of CAPE were used to assess its effects on motility, viability and microfilarial (mf) production of B. pahangi in vitro. Anti-Wolbachial activity of CAPE was measured in worms by quantification of Wolbachial wsp gene copy number using real-time polymerase chain reaction. Our findings show that CAPE was found to significantly reduce adult worm motility, viability, and mf release both in vitro and in vivo. 20 μg/ml of CAPE halts the release of mf in vitro by day 6 of post treatment. Also, the number of adult worms recovered in vivo were reduced significantly during and after treatment with 50 mg/kg of CAPE relative to control drugs, diethylcarbamazine and doxycycline. Real time PCR based on the Wolbachia ftsZ gene revealed a significant reduction in Wolbachia copy number upon treatment. Anti-Wolbachia and antifilarial properties of CAPE require further investigation as an alternative strategy to treat LF.
- Open Access
- 30 June 2016
- Published by Korean Society for Parasitology in The Korean Journal of Parasitology
- Vol. 54 (3) , 273-280
Antifilarial and Antibiotic Activities of Methanolic Extracts of Melaleuca cajuputi Flowers
We evaluated the activity of methanolic extracts of Melaleuca cajuputi flowers against the filarial worm Brugia pahangi and its bacterial endosymbiont Wolbachia. Anti-Wolbachia activity was measured in worms and in Aedes albopictus Aa23 cells by PCR, electron microscopy, and other biological assays. In particular, microfilarial release, worm motility, and viability were determined. M. cajuputi flower extracts were found to significantly reduce Wolbachia endosymbionts in Aa23 cells, Wolbachia surface protein, and microfilarial release, as well as the viability and motility of adult worms. Anti-Wolbachia activity was further confirmed by observation of degraded and phagocytized Wolbachia in worms treated with the flower extracts. The data provided in vitro and in vivo evidence that M. cajuputi flower extracts inhibit Wolbachia, an activity that may be exploited as an alternative strategy to treat human lymphatic filariasis.
- 30 June 2016
- Published by Korean Society for Parasitology in The Korean Journal of Parasitology
- Vol. 54 (3) , 273-280
Open AccessAntifilarial and Antibiotic Activities of Methanolic Extracts of Melaleuca cajuputi Flowers
We evaluated the activity of methanolic extracts of Melaleuca cajuputi flowers against the filarial worm Brugia pahangi and its bacterial endosymbiont Wolbachia. Anti-Wolbachia activity was measured in worms and in Aedes albopictus Aa23 cells by PCR, electron microscopy, and other biological assays. In particular, microfilarial release, worm motility, and viability were determined. M. cajuputi flower extracts were found to significantly reduce Wolbachia endosymbionts in Aa23 cells, Wolbachia surface protein, and microfilarial release, as well as the viability and motility of adult worms. Anti-Wolbachia activity was further confirmed by observation of degraded and phagocytized Wolbachia in worms treated with the flower extracts. The data provided in vitro and in vivo evidence that M. cajuputi flower extracts inhibit Wolbachia, an activity that may be exploited as an alternative strategy to treat human lymphatic filariasis.
- Open Access
- 24 October 2015
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 15 (1) , 1-13
Antioxidant, antibacterial activity, and phytochemical characterization of Melaleuca cajuputi extract
The threat posed by drug-resistant pathogens has resulted in the increasing momentum in research and development for effective alternative medications. The antioxidant and antibacterial properties of phytochemical extracts makes them attractive alternative complementary medicines. Therefore, this study evaluated the phytochemical constituents of Melaleuca cajuputi flower and leaf (GF and GL, respectively) extracts and their antioxidant and antibacterial activities. Radical scavenging capacity of the extracts was estimated using 2,2-diphenyl-2-picrylhydrazyl and Fe2+-chelating activity. Total antioxidant activity was determined using ferric reducing antioxidant power assay. Well diffusion, minimum inhibitory concentration, and minimum bactericidal concentration assays were used to determine antibacterial activity against eight pathogens, namely Staphylococcus aureus, Escherichia coli, Bacillus cereus, Staphylococcus epidermidis, Salmonella typhimurium, Klebsiella pneumonia, Streptococcus pneumoniae, and Pasteurella multocida. We identified and quantified the phytochemical constituents in methanol extracts using liquid chromatography/mass spectrometry (LC/MS) and gas chromatography (GC)/MS. This study reports the antioxidant and radical scavenging activity of M. cajuputi methanolic extracts. The GF extract showed better efficacy than that of the GL extract. The total phenolic contents were higher in the flower extract than they were in the leaf extract (0.55 ± 0.05 and 0.37 ± 0.05 gallic acid equivalent per mg extract dry weight, respectively). As expected, the percentage radical inhibition by GF was higher than that by the GL extract (81 and 75 %, respectively). A similar trend was observed in Fe2+-chelating activity and β-carotene bleaching tests. The antibacterial assay of the extracts revealed no inhibition zones with the Gram-negative bacteria tested. However, the extracts demonstrated activity against B. cereus, S. aureus, and S. epidermidis. In this study, we found that M. cajuputi extracts possess antioxidant and antibacterial activities. The results revealed that both extracts had significant antioxidant and free radical-scavenging activity. Both extracts had antibacterial activity against S. aureus, S. epidermidis, and B. cereus. The antioxidant and antimicrobial activities could be attributed to high flavonoid and phenolic contents identified using GC/MS and LC/MS. Therefore, M. cajuputi could be an excellent source for natural antioxidant and antibacterial agents for medical and nutraceutical applications.
- 24 October 2015
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 15 (1) , 1-13
Open AccessAntioxidant, antibacterial activity, and phytochemical characterization of Melaleuca cajuputi extract
The threat posed by drug-resistant pathogens has resulted in the increasing momentum in research and development for effective alternative medications. The antioxidant and antibacterial properties of phytochemical extracts makes them attractive alternative complementary medicines. Therefore, this study evaluated the phytochemical constituents of Melaleuca cajuputi flower and leaf (GF and GL, respectively) extracts and their antioxidant and antibacterial activities. Radical scavenging capacity of the extracts was estimated using 2,2-diphenyl-2-picrylhydrazyl and Fe2+-chelating activity. Total antioxidant activity was determined using ferric reducing antioxidant power assay. Well diffusion, minimum inhibitory concentration, and minimum bactericidal concentration assays were used to determine antibacterial activity against eight pathogens, namely Staphylococcus aureus, Escherichia coli, Bacillus cereus, Staphylococcus epidermidis, Salmonella typhimurium, Klebsiella pneumonia, Streptococcus pneumoniae, and Pasteurella multocida. We identified and quantified the phytochemical constituents in methanol extracts using liquid chromatography/mass spectrometry (LC/MS) and gas chromatography (GC)/MS. This study reports the antioxidant and radical scavenging activity of M. cajuputi methanolic extracts. The GF extract showed better efficacy than that of the GL extract. The total phenolic contents were higher in the flower extract than they were in the leaf extract (0.55 ± 0.05 and 0.37 ± 0.05 gallic acid equivalent per mg extract dry weight, respectively). As expected, the percentage radical inhibition by GF was higher than that by the GL extract (81 and 75 %, respectively). A similar trend was observed in Fe2+-chelating activity and β-carotene bleaching tests. The antibacterial assay of the extracts revealed no inhibition zones with the Gram-negative bacteria tested. However, the extracts demonstrated activity against B. cereus, S. aureus, and S. epidermidis. In this study, we found that M. cajuputi extracts possess antioxidant and antibacterial activities. The results revealed that both extracts had significant antioxidant and free radical-scavenging activity. Both extracts had antibacterial activity against S. aureus, S. epidermidis, and B. cereus. The antioxidant and antimicrobial activities could be attributed to high flavonoid and phenolic contents identified using GC/MS and LC/MS. Therefore, M. cajuputi could be an excellent source for natural antioxidant and antibacterial agents for medical and nutraceutical applications.